Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 6/20 | 0.84 |
| ▸ | PDE3A | Q14432 | 6/20 | 0.84 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.84 |
| ▸ | MAOA | P21397 | 1/20 | 0.84 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.84 |
| ▸ | GPR119 | Q8TDV5 | 9/20 | 0.61 |
| ▸ | PDE4A | P27815 | 2/20 | 0.58 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.58 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.58 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | F10 | P00742 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pimobendan SCHEMBL14815175 | 1.00 | PDE3B (0.84) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL29386190 | 1.00 | PDE3B (0.84) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL15617988 | 1.00 | PDE3B (0.84) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL2466855 | 1.00 | PDE3B (0.84) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL668129 | 0.99 | PDE3B (0.83) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL1996787 | 0.99 | PDE3B (0.83) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL1997246 | 0.98 | PDE3B (0.81) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL1993626 | 0.95 | PDE3B (0.77) | PDE3BPDE3AABCB11MAOAADORA2A | |
| Pimobendan SCHEMBL1649737 | 0.92 | PDE3B (1.00) | PDE3BPDE3AABCB11MAOAADORA2A | |
| SCHEMBL9781454 | 0.87 | PDE3B (0.64) | PDE3BPDE3AABCB11MAOAADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5374 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108532-A1 | COMPOSITION FOR PREVENTING HEART DISEASES CAUSED BY PULMONARY HYPERTENSION AND TREATING HEART, AND FUNCTIONAL FORMULATION COMPRISING SAME | CARESIDE CO., LTD. (KR) | 2026-04-23 | — | — | US | claimed |
| US-12605366-B2 | Telmisartan for the treatment of hypertension in dogs | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2026-04-21 | — | — | US | claimed |
| EP-4719429-A1 | COMBINATION TREATMENT AND/OR PREVENTION OF CARDIAC DISEASES IN NON-HUMAN MAMMALS COMPRISING ONE OR MORE SGLT-2 INHIBITORS AND PIMOBENDAN AND/OR TELMISARTAN | Boehringer Ingelheim Vetmedica GmbH (DE) | 2026-04-08 | — | — | EP | claimed |
| WO-2025243113-A1 | METHODS FOR PREPARING A PHARMACEUTICAL COMPOSITION HAVING IMPROVED SOLUBILITY AND USES THEREOF | LUBBE JACQUES (ZA) | 2025-11-27 | — | — | WO | claimed |
| EP-4643859-A1 | COMPOSITION FOR PREVENTING HEART DISEASES CAUSED BY PULMONARY HYPERTENSION AND TREATING HEART, AND FUNCTIONAL FORMULATION COMPRISING SAME | Careside Co., Ltd. (KR) | 2025-11-05 | — | — | EP | claimed |
| EP-4633607-A1 | SOLID DISPERSIONS COMPRISING AMORPHOUS PIMOBENDAN AND ONE OR MORE STABILIZING POLYMERS | Boehringer Ingelheim Vetmedica GmbH (DE) | 2025-10-22 | — | — | EP | claimed |
| US-20250295787-A1 | PRESERVED ETHERIFIED CYCLODEXTRIN DERIVATIVES CONTAINING LIQUID AQUEOUS PHARMACEUTICAL COMPOSITION | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2025-09-25 | — | — | US | claimed |
| EP-4590693-A2 | GENE THERAPY METHODS FOR TREATING MITRAL VALVE DISEASE | Rejuvenate Bio Inc (US) | 2025-07-30 | — | — | EP | claimed |
| US-12357696-B2 | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2025-07-15 | — | — | US | claimed |
| EP-4580603-A2 | SOFT CHEWABLE FORMULATIONS WITH ACTIVE INGREDIENTS | Noble Pharma, LLC (US) | 2025-07-09 | — | — | EP | claimed |
| WO-1999014239-A1 | COMPOSITION FOR TREATING DIABETES MELLITUS AND OBESITY | FORSSMANN WOLF GEORG (DE) | 1999-03-25 | — | — | WO | claimed |
| WO-1998031380-A1 | PHALLOIDIN DERIVATIVES AND ANALOGS TO TREAT CONGESTIVE HEART FAILURE | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1998-07-23 | — | — | WO | claimed |
| WO-1998010765-A1 | NON-HORMONAL METHOD OF CONTRACEPTION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 1998-03-19 | — | — | WO | claimed |
| EP-0764021-A1 | UTERINE FIBROID TREATMENT | THE UNIVERSITY OF BIRMINGHAM (GB) | 1997-03-26 | — | — | EP | claimed |
| WO-1995033454-A1 | UTERINE FIBROID TREATMENT | THE UNIVERSITY OF BIRMINGHAM (GB) | 1995-12-14 | — | — | WO | claimed |
| US-5364646-A | Powdered mixture with citric acid; pH insensitive | DR. KARL THOMAE GMBH (DE) | 1994-11-15 | — | — | US | claimed |
| EP-0330052-B1 | Use of benzimidazoles for preparing a medicine with an anti-ischemial activity on the heart, and combinations with betablockers or bradycardics | THOMAE GMBH DR K (DE) | 1993-12-15 | — | — | EP | claimed |
| EP-0439030-B1 | ORAL DOSAGE FORMS CONTAINING PIMOBENDAN | Dr. Karl Thomae GmbH (DE) | 1993-03-31 | — | — | EP | claimed |
| EP-0439030-A2 | Oral dosage forms containing pimobendan | Dr. Karl Thomae GmbH (DE) | 1991-07-31 | — | — | EP | claimed |
| EP-0306846-A2 | Synergistic combination comprising a phosphodiesterase inhibitor and a thromboxane-A2 antagonist, and its use or preparation | Dr. Karl Thomae GmbH (DE) | 1989-03-15 | — | — | EP | claimed |